Skip to main content
logo
Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
20.00
+0.56 (2.88%)
Jul 28, 2026, 4:00 PM EDT - Market closed

Vor Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,084506139153439432
Market Cap Growth
294.21%265.67%-9.35%-65.19%1.60%-
Enterprise Value
595.1354.2578.4151.26247.54242.51
Last Close Price
20.0013.0822.2045.00133.00232.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
--3.081.431.011.752.00
P/TBV Ratio
--0.791.001.051.80

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.02-0.020.290.210.140.07
Net Debt / Equity Ratio
3.252.75-0.62-0.67-0.76-0.88
Net Debt / EBITDA Ratio
1.331.250.530.832.192.93
Net Debt / FCF Ratio
3.243.150.601.002.042.59
Quick Ratio
30.5718.084.948.8117.5520.43
Current Ratio
31.1518.205.199.0418.0621.12
Return on Equity (ROE)
561.16%2057.65%-94.52%-58.74%-39.45%-52.09%
Return on Assets (ROA)
-76.94%-122.45%-71.07%-50.67%-34.47%-43.34%
Return on Invested Capital (ROIC)
-5940.06%-1306.30%-216.88%-198.73%-195.19%-239.25%
Return on Capital Employed (ROCE)
-80.36%-131.97%-78.99%-53.77%-36.02%-46.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-359.89%-187.35%-2.26%-69.89%-18.30%0.00%
Total Shareholder Return
-359.89%-187.35%-2.26%-69.89%-18.30%0.00%
SEC Filings: 10-K · 10-Q